Results 1 to 10 of about 29,544 (120)

Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination

Case Reports in Dermatological Medicine, 2022
SARS-CoV-2 vaccines were approved without long-term monitoring due to emergent situation and might have several side effects. Herein, we describe the first case with development of both LP and PV following COVID-19 vaccination.
Zeinab Aryanian, Kamran Balighi, Arghavan Azizpour, Kambiz Kamyab Hesari, Parvaneh Hatami   +4 more
doaj   +1 more source

Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management

Orphanet Journal of Rare Diseases, 2023
Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious and rare diseases, most often drug-induced, and their incidence has been estimated at 6 cases/million/year in France. SJS and TEN belong to the same spectrum of disease known
Dhyna Thorel, Saskia Ingen-Housz-Oro, Daniel Benaïm, Vincent Daien, Eric Gabison, Valentine Saunier, Laurence Béral, David Touboul, Dominique Brémond-Gignac, Matthieu Robert, Robin Vasseur, Gérard Royer, Olivier Dereure, Brigitte Milpied, Claire Bernier, Anne Welfringer-Morin, Christine Bodemer, Nadège Cordel, Marie Tauber, Carole Burillon, Marion Servant, Chloe Couret, Bertrand Vabres, Florence Tétart, Myriam Cassagne, Marie-Ange Kuoch, Marc Muraine, Agnès Delcampe, Julie Gueudry   +28 more
doaj   +1 more source

Coexistence of Neonatal Lupus Erythematous and Sturge–Weber Syndrome

Case Reports in Dermatological Medicine, 2021
Neonatal lupus erythematous (NLE) is a rare condition presented by lupus dermatitis shortly after birth or later following sun exposure. Sturge–Weber syndrome (SWS) is also an uncommon congenital condition characterized by extensive capillary ...
Zahra Nikyar, Parvaneh Hatami, Zeinab Aryanian, Kambiz Kamyab Hesari, Azadeh Goodarzi, Anahita Borzouei   +5 more
doaj   +1 more source

Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab‐treated and rituximab‐naïve patients

Dermatologic Therapy, 2022
Rituximab (RTX) combined with short‐term glucocorticoids (GC) is an effective therapeutic option for pemphigus. The newly developed Glucocorticoid Toxicity Index (GTI) tool provides the possibility to measure GC toxicities over time.
Elham Mazaherpour, Nika Kianfar, Shayan Dasdar, Mojtaba Sedaghat, Hassan Seyrafi, Kamran Balighi, Fatemeh Saberi, Ali Nili, Zeinab Farimani, Pedram Molhem Azar, Hamidreza Mahmoodi, Dedee F. Murrell, Maryam Daneshpazhooh   +12 more
doaj   +1 more source

Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey

Case Reports in Dermatology, 2022
Scleromyxedema is a rare but important mucinosis disorder of the skin that is presented with dermatological manifestations such as waxy papules, diffuse induration, and nondermatologic involvements like neurological and renal disorders.
Abtin Ansari, Zohre Erfani, Maryam Daneshpazhooh, Leila Mahmoudi, Zahra Saffarian, Kambiz Kamyab, Hamidreza Mahmoudi   +6 more
doaj   +1 more source

Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases

Clinical Case Reports, 2023
Key Clinical Message The immunosuppressant agents should be considered earlier in the course of treatment with rituximab, possibly after the unfavorable response at first cycle of treatment, especially in male patients and those with high BMI.
Zeinab Aryanian, Insha Zainab Riyaz, Kamran Balighi, Ali Ahmadzade, Hamid Reza Mahmoudi, Arghavan Azizpour, Parvaneh Hatami   +6 more
doaj   +1 more source

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy

International Journal of Women's Dermatology, 2022
Background: . Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. Objectives: .
Azin Dehghanimahmoudabadi, MD, Nika Kianfar, MD, MPH, Marwa Akhdar, MD, Shayan Dasdar, MD, MPH, Kamran Balighi, MD, Hamidreza Mahmoudi, MD, Maryam Daneshpazhooh, MD   +6 more
doaj   +1 more source

An Unusual TEN-Like Presentation of Juvenile Bullous Pemphigoid: A Diagnostic Challenge

Case Reports in Dermatological Medicine, 2022
Bullous pemphigoid (BP) is an acquired autoimmune bullous disorder rarely seen in the pediatric population. It usually presents as large and tense bullae, predominantly distributed in the acral areas.
Zahra Nikyar, Parvaneh Hatami, Zeinab Aryanian, Soheila Sotoudeh, Vahid Ziaee, Azadeh Goodarzi   +5 more
doaj   +1 more source

Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris

International Journal of Women's Dermatology, 2020
Background: Autoimmune bullous diseases are a group of rare, chronic, blistering diseases, with pemphigus vulgaris (PV) being the most common type in Iran.
Amir Teimourpour, PhD, Kowsar Hedayat, MD, Fereshteh Salarvand, MD, Narges Ghandi, MD, Maryam Ghiasi, MD, Hamidreza Mahmoudi, MD, Kamran Balighi, MD, Roja Toosi, MD, MPH, Farnam Mohebi, MD, MPH, Ali Nili, MD, Maryam Daneshpazhooh, MD, Dedee F. Murrell, MA, BMBCh, MD, FACD, Cheyda Chams-Davatchi, MD   +12 more
doaj   +1 more source

Two asymptomatic facial erythematous macules in an adult male

Skin Health and Disease, 2023
Pemphigus is a group of autoimmune bullous disorders with different types. Pemphigus foliaceous (PF) is a difficult‐to‐diagnosis disorder which shares clinical features with many dermatoses.
Kamran Balighi, Kambiz Kamyab‐hesari, Parvaneh Hatami, Zeinab Aryanian   +3 more
doaj   +1 more source